144 related articles for article (PubMed ID: 3288377)
1. Neopterin and beta 2-microglobulin in serum of HIV-seropositive subjects during a two-year follow-up.
Lambin P; Lefrere JJ; Doinel C; Fine JM; Salmon D; Salmon C
Clin Chem; 1988 Jun; 34(6):1367-8. PubMed ID: 3288377
[No Abstract] [Full Text] [Related]
2. Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS.
Krown SE; Niedzwiecki D; Bhalla RB; Flomenberg N; Bundow D; Chapman D
J Acquir Immune Defic Syndr (1988); 1991; 4(9):871-80. PubMed ID: 1895208
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
4. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A
Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488
[TBL] [Abstract][Full Text] [Related]
5. Serum neopterin and beta 2-microglobulin in anti-HIV positive blood donors.
Lambin P; Desjobert H; Debbia M; Fine JM; Muller JY
Lancet; 1986 Nov; 2(8517):1216. PubMed ID: 2877345
[No Abstract] [Full Text] [Related]
6. Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection.
Fuchs D; Krämer A; Reibnegger G; Werner ER; Dierich MP; Goedert JJ; Wachter H
Infection; 1991; 19 Suppl 2():S98-102. PubMed ID: 1673120
[TBL] [Abstract][Full Text] [Related]
7. Study of beta-2 microglobulin and neopterin in serum and cerebrospinal fluid of HIV-infected patients.
Imberciadori G; Piersantelli N; Bo A; Calderisi S; Emanuelli F; Marchetto E; Penco G; Farinelli M; Arata L; Ribizzi G
Acta Neurol (Napoli); 1990 Feb; 12(1):58-61. PubMed ID: 2186603
[No Abstract] [Full Text] [Related]
8. Neopterin, beta 2-microglobulin, and acute phase proteins in HIV-1-seropositive and -seronegative Zambian patients with tuberculosis.
Hosp M; Elliott AM; Raynes JG; Mwinga AG; Luo N; Zangerle R; Pobee JO; Wachter H; Dierich MP; McAdam KP; Fuchs D
Lung; 1997; 175(4):265-75. PubMed ID: 9195554
[TBL] [Abstract][Full Text] [Related]
9. Surrogate markers for AIDS treatment.
Jacobson M
Nurs Times; 1991 May 29-Jun 4; 87(22):49. PubMed ID: 1675013
[No Abstract] [Full Text] [Related]
10. Elevated neopterin and beta 2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infection.
Sönnerborg AB; von Stedingk LV; Hansson LO; Strannegård OO
AIDS; 1989 May; 3(5):277-83. PubMed ID: 2504231
[TBL] [Abstract][Full Text] [Related]
11. Neopterin and beta 2-microglobulin as serum markers in a placebo-controlled anti-HIV therapy trial.
Carstens J; Teglbjaerg LS; Black FT
Eur J Clin Chem Clin Biochem; 1995 Sep; 33(9):559-62. PubMed ID: 8611664
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum neopterin and serum beta 2-microglobulin in subjects with lung infections.
Carstens J; Andersen PL
Eur Respir J; 1994 Jul; 7(7):1233-8. PubMed ID: 7925900
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of soluble interleukin 2 receptors in HIV infection: correlation studies with markers of cell activation.
Lang JM; Coumaros G; Levy S; Falkenrodt A; Steckmeyer M; Partisani M; Aleksijevic A; Lehr L; Koehl C
Immunol Lett; 1988 Oct; 19(2):99-102. PubMed ID: 3069705
[No Abstract] [Full Text] [Related]
14. Neopterin and opportunistic infections in HIV-infected patients.
Domingo P; Martínez E; Martínez C; Barrio J; Cadafalch J
Clin Investig; 1993 Jan; 71(1):65. PubMed ID: 8453262
[No Abstract] [Full Text] [Related]
15. Neopterin and beta-2 microglobulin levels in asymptomatic HIV infection: the predictive value of combining markers.
Harrison NA; Skidmore SJ
J Med Virol; 1990 Oct; 32(2):128-33. PubMed ID: 2126281
[TBL] [Abstract][Full Text] [Related]
16. Close relationships between neopterin and beta-2-microglobulin levels in intravenous drug abusers.
Lin RY; Nygren E; Valinsky J; Lorenzana FG; Ralph H
Int Arch Allergy Appl Immunol; 1990; 91(4):389-93. PubMed ID: 1976599
[TBL] [Abstract][Full Text] [Related]
17. [Interview with Dr. W. Stille, Frankfurt. Will AIDS-suspected blood donors soon be identifiable?].
Stille W
MMW Munch Med Wochenschr; 1983 Dec; 125(48):suppl 25. PubMed ID: 6419073
[No Abstract] [Full Text] [Related]
18. Markers of risk in HIV-1.
Krämer A; Biggar RJ; Goedert JJ
N Engl J Med; 1990 Jun; 322(26):1886. PubMed ID: 1971915
[No Abstract] [Full Text] [Related]
19. Neopterin radioimmunoassay results are unaffected by beta-propiolactone: safer monitoring of HIV-positive serum samples.
Sheldon J; Riches P; Hobbs JR
Clin Chem; 1990 Jan; 36(1):175. PubMed ID: 2404641
[No Abstract] [Full Text] [Related]
20. Early levels of CD4, neopterin, and beta 2-microglobulin indicate future disease progression.
Shi M; Taylor JM; Fahey JL; Hoover DR; Muñoz A; Kingsley LA
J Clin Immunol; 1997 Jan; 17(1):43-52. PubMed ID: 9049785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
